<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02927665</url>
  </required_header>
  <id_info>
    <org_study_id>ReShape Post Approval Study</org_study_id>
    <nct_id>NCT02927665</nct_id>
  </id_info>
  <brief_title>A Prospective Multicenter Post Approval Study of the ReShape™ Integrated Dual Balloon System in Obese Subjects</brief_title>
  <acronym>ReShapePAS</acronym>
  <official_title>A Prospective Multicenter Post Approval Study of the ReShape™ Integrated Dual Balloon System in Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ReShape Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ReShape Lifesciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ReShape Post Approval Study is a prospective multicenter study of the ReShape(TM)
      Integrated Dual Balloon System in Obese Subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ReShape Post Approval Study is a post-approval, multicenter, single arm, open label
      clinical study intended to collect valid scientific evidence regarding the safety and
      efficacy of the ReShape Dual Balloon as an adjunct to diet and exercise in the treatment of
      BMI 30-40 subjects with one or more obesity-related comorbid conditions in a commercial
      clinical setting.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Safety of ReShape Dual Balloon Treatment</measure>
    <time_frame>24 weeks</time_frame>
    <description>Safety of ReShape Dual Balloon Treatment using a composite endpoint consisting of all device- and/or procedure-related SAEs</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Study Subjects</arm_group_label>
    <description>Eligible subjects receiving ReShape Integrated Dual Balloon System treatment in a commercial clinical setting</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Reshape Integrated Dual Balloon</intervention_name>
    <arm_group_label>Study Subjects</arm_group_label>
    <other_name>Reshape Integrated Dual Balloon System</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Obese patients with a body mass index (BMI) of 30-40 and one or more obesity-related
        comorbid conditions, who have failed weight reduction with diet and exercise alone
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Ages 22 and older

          2. Baseline BMI 30 - 40

          3. Failed weight reduction with diet and exercise alone

          4. One or more obesity-related comorbid conditions

          5. If female of child bearing potential, willing to avoid pregnancy during course of
             treatment

        Exclusion Criteria:

          1. Prior gastrointestinal surgery with sequelae, i.e. obstruction, and/or adhesive
             peritonitis or known abdominal adhesions

          2. Prior open or laparoscopic bariatric surgery.

          3. Any inflammatory disease of the gastrointestinal tract including esophagitis, gastric
             ulceration, duodenal ulceration, cancer or specific inflammation such as Crohn's
             disease.

          4. Potential upper gastrointestinal bleeding conditions such as esophageal or gastric
             varices, congenital or acquired intestinal telangiectasis, or other congenital
             anomalies of the gastrointestinal tract such as atresias or stenoses.

          5. A gastric mass.

          6. A hiatal hernia &gt; 5 cm or ≤ 5 cm with associated severe or intractable
             gastro-esophageal reflux symptoms.

          7. A structural abnormality in the esophagus or pharynx such as a stricture or
             diverticulum that could impede passage of the delivery catheter and/or an endoscope.

          8. Achalasia or any other severe esophageal motility disorder that may pose a safety risk
             during the removal of the device

          9. Severe coagulopathy

         10. Hepatic insufficiency or cirrhosis

         11. Serious or uncontrolled psychiatric illness or disorder that could compromise patient
             understanding of or compliance with follow up visits and removal of the device after 6
             months.

         12. Alcoholism or drug addiction.

         13. Patients unwilling to participate in an established medically-supervised diet and
             behavior modification program, with routine medical follow-up.

         14. Patients receiving daily prescribed treatment with aspirin, anti-inflammatory agents,
             anticoagulants or other gastric irritants.

         15. Patients who are unable or unwilling to take prescribed proton pump inhibitor
             medication for the duration of the device implant.

         16. Patients who are known to have, or suspected to have, an allergic reaction to
             materials contained in the system.

         17. Patients who have ever developed a serotonin syndrome and are currently taking any
             drug known to affect the levels of serotonin in the body [e.g., selective serotonin
             reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs),
             monoamine oxidase inhibitors (MAOIs)] should not undergo placement of the device.

         18. Patients who are pregnant or breast-feeding.

         19. Significant endoscopic abnormalities immediately prior to device insertion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott Shikora</last_name>
    <role>Study Director</role>
    <affiliation>ReShape Lifesciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alina Stoica</last_name>
    <email>astoica@reshapelifesci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Missy Broich</last_name>
    <email>mbroich@reshapelifesci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Advanced Surgeons, P.C.</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35243</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle Brown</last_name>
      <phone>205-595-8985</phone>
    </contact>
    <investigator>
      <last_name>John Touliatos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>W S Pennington, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Digestive Health Specialists of the Southeast</name>
      <address>
        <city>Dothan</city>
        <state>Alabama</state>
        <zip>36305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawn Barnes, RN</last_name>
      <phone>334-836-3341</phone>
      <email>dbarnes@dothangi.com</email>
    </contact>
    <investigator>
      <last_name>Travis J Rutland, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Christiana Institute of Advanced Surgery</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalia L Co</last_name>
      <phone>302-892-9900</phone>
      <email>nco@chrias.com</email>
    </contact>
    <investigator>
      <last_name>Isaias Irgau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barrington Surgeons</name>
      <address>
        <city>Barrington</city>
        <state>Illinois</state>
        <zip>60010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Wool, MD</last_name>
      <email>lharr@barringtonsurgeons.com</email>
    </contact>
    <investigator>
      <last_name>Daniel Wool, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Hoeltgen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Gastro Clinic</name>
      <address>
        <city>Lafayette</city>
        <state>Louisiana</state>
        <zip>70503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tasha Cieslak</last_name>
      <phone>337-232-6697</phone>
      <email>tasha@gastroclinic.com</email>
    </contact>
    <investigator>
      <last_name>Eric Trawick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacob Karr, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Surgical Specialist of Louisiana</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Perilloux</last_name>
      <phone>504-934-3000</phone>
      <email>jperilloux@whyweight.com</email>
    </contact>
    <investigator>
      <last_name>Thomas Lavin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abigail Lowe, RD</last_name>
      <phone>314-747-1264</phone>
      <email>a.e.lowe@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Vladimir Kushnir, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dayna Early, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Jersey Laparoscopic Associates</name>
      <address>
        <city>Teaneck</city>
        <state>New Jersey</state>
        <zip>07666</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stella Z Fee</last_name>
      <phone>201-530-1900</phone>
      <email>stella@northjerseybariatrics.com</email>
    </contact>
    <investigator>
      <last_name>Stefanie Vaimakis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Bariatric Group</name>
      <address>
        <city>Roslyn Heights</city>
        <state>New York</state>
        <zip>11577</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Franco, R-PA</last_name>
      <phone>516-616-5500</phone>
      <email>donna@nybg.com</email>
    </contact>
    <investigator>
      <last_name>Shawn Garber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>JourneyLite Physicians</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45241</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Ledonne</last_name>
      <phone>513-475-3663</phone>
      <email>erin@curryweightloss.com</email>
    </contact>
    <investigator>
      <last_name>Trace Curry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Salem General Surgery</name>
      <address>
        <city>Salem</city>
        <state>Ohio</state>
        <zip>44460</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Pulido, MD</last_name>
      <phone>330-337-2868</phone>
    </contact>
    <investigator>
      <last_name>Jonathan Pulido, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gastrointestinal Associates, P.C.</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37909</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Karnes, RN</last_name>
      <phone>865-558-0687</phone>
      <email>kkarnes@gihealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Bergein F Overholt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles M O'Connor, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Johnny Altawil, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MidSouth Bariatrics</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dory Sims, RN</last_name>
      <phone>901-869-2000</phone>
      <email>nurse@clubnewyou.com</email>
    </contact>
    <investigator>
      <last_name>George Woodman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sage Bariatric Institute</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78240</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Jensen</last_name>
      <phone>210-651-0303</phone>
      <email>heidi@sagebariatric.com</email>
    </contact>
    <investigator>
      <last_name>John Pilcher, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eviva</name>
      <address>
        <city>Shoreline</city>
        <state>Washington</state>
        <zip>98155</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josiah Billing, BS</last_name>
      <phone>425-778-2220</phone>
      <phone_ext>109</phone_ext>
      <email>jbilling@evivamd.com</email>
    </contact>
    <investigator>
      <last_name>Peter S Billing, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2016</study_first_submitted>
  <study_first_submitted_qc>October 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2016</study_first_posted>
  <last_update_submitted>April 5, 2018</last_update_submitted>
  <last_update_submitted_qc>April 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Weight Loss</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

